Navigation Links
BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009
Date:1/14/2009

ch statements are subject to a multitude of risks and uncertainties that could cause actual results, future circumstances, or events to differ materially from those projected in the forward-looking information. These risks include, but are not limited to, those associated with our capacity to finance our activities, the adequacy, timing, and results of our clinical trials, the regulatory approval process, competition, securing and maintaining corporate alliances, market acceptance of the Company's products, the availability of government and insurance reimbursements for the Company's products, the strength of intellectual property, the success of research and development programs, reliance on subcontractors and key personnel, and other risks and uncertainties detailed from time-to-time in our filings with the Canadian securities commissions.

Readers should not place undue reliance on the forward-looking information, given that (i) our actual results could differ materially from a conclusion, forecast or projection in the forward-looking information, and (ii) certain material factors or assumptions which were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information, could prove to be inaccurate. Additional information about (i) the material factors that could cause actual results to differ materially from the conclusion, forecast or projection in the forward-looking information, and (ii) the material factors or assumptions that were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information, is contained in the Company's annual report and other documents filed from time to time with the Canadian securities commissions which are available at www.sedar.com. These statements speak only as of the date they are made, and we assume no obligation to revise such statements as a result of any event, circumst
'/>"/>

SOURCE BioSyntech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
2. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
3. West Concludes Agreement with Nektar
4. Workforce Alliance Concludes Three-Year Biotech Training Program
5. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
6. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
7. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
8. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
9. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Md. , April 1, 2015  VLP Therapeutics, ... company focusing on the research and development of therapeutic ... upon a novel and proprietary vaccine technology, today announced ... Institute of Tropical Medicine at Nagasaki ... collaboration will facilitate VLP,s research and development of dengue ...
(Date:4/1/2015)... Proove Biosciences , a commercial and ... scientific posters at the Annual Clinical Genetics Meeting in ... was hosted at the Salt Palace Convention Center and ... and genomic professionals on breakthrough advances in clinical genetics. ... the Role of DAT1 in Risk of Insomnia on ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and ... the addition of the "Forensic Technologies and ... to their offering. This report analyzes ... in US$ Million by the following Segments: Forensic ... Testing, and Others. Annual estimates and ...
(Date:4/1/2015)... NEW YORK CITY and LONDON ... provider of market research reports and solutions, MarketResearch.com is pleased ... 2015 will be a year of market growth and opportunity ... a stem cell company or cord blood bank, competing in ... analyze market conditions, predict industry trends, and act on market ...
Breaking Biology Technology:VLP Therapeutics Enters Collaboration with Institute of Tropical Medicine, Nagasaki University 2VLP Therapeutics Enters Collaboration with Institute of Tropical Medicine, Nagasaki University 3Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015 2Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 2Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 3Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 4Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 5Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 6Forensic Technologies and Services - Global Strategic Business Report 2015-2020: Rise in Terrorist Bombings Sharpens the Business Case for Explosives Forensics 7MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4
... MEDFORD/SOMERVILLE, Mass. -- Promising research on superconducting materials, near ... Tufts University,s School of Engineering early career awards from ... The awards are among the most prestigious honors given ... at the early stages of their careers, when many ...
... March 23 The Superior Court of Pennsylvania has reinstated an appeal filed by ... been dismissed by an order from the same court on February 18, 2010 . The Superior Court also ... ... , ...
... - and authorities on the track of illicit alcohol ... hand. Measurement experts have unveiled a portable device to ... almost anywhere. Published in the open access Chemistry ... is just as accurate, and more sophisticated, than widely ...
Cached Biology Technology:3 Tufts engineering faculty earn prestigious national awards for promising research 23 Tufts engineering faculty earn prestigious national awards for promising research 3UPDATE: Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated 2How strong is your booze? 2
(Date:3/18/2015)... March 18, 2015 As mobile payments ... revolutionary smart wallets and apps continue to be introduced into ... in the mobile payment industry in focus today are:  NXT-ID, ... (NYSE: BABA ), Apple Inc. (NASDAQ: ... Facebook Inc. (NASDAQ: FB ) NXT-ID, ...
(Date:3/16/2015)... 16, 2015 Between 16 ... present groundbreaking innovations in biometric identification at the ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... is well at the forefront: the company,s all ... in Germany . BiometricGate is ...
(Date:3/12/2015)... March 12, 2015 WHEN:Tuesday, March 17, 2015 ... http://bit.ly/1G7Os0L . SPEAKERS: , Frost & Sullivan ... http://photos.prnewswire.com/prnh/20150311/181111 Biometric companies must ... in several different markets and industries. This is ... an uptrend. Join Frost & ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... RIVERSIDE, Calif. ( www.ucr.edu ) -- A team led ... Bourns College of Engineering has made a discovery in ... from kill viruses to increase storage capacity of DVDs. ... data processing, information storage and biology. Their applications have ...
... 19th conference of the International Society for Sexually Transmitted ... in Quebec City, Canada. The world,s foremost conference ... 1,200 scientists from every continent to discuss the most ... and treatment; emerging threats in bacterial STDs; major intervention ...
... Spanish . The last of seven cotton ... a major 4-year cotton gin dust sampling project draws to ... project to intensively sample emissions from seven cotton gins across ... Research Service (ARS) Cotton Production and Processing Research Unit in ...
Cached Biology News:New laser technology could kill viruses and improve DVDs 2ARS and cooperators study cotton gin dust emissions 2
... For separation ... proteins Efficient separation of nuclei ... reduction in sample complexity, greatly ... proteins Subfractionation of nucleic acid ...
... balanced salt solution. It is routinely used as ... whole blood at refrigerator temperatures for approximately 10 ... is collected into a container of this product ... placed in a refrigerator at 2-8 C for ...
... a fixative useful for routine procedures. Hollandes ... stable and will decalcify small bone specimens. ... be stained successfully with most stains, and ... red blood cell membranes and cosinophil and ...
... The Precision XS uniquely combines a single-channel ... and an 8-channel bulk reagent dispenser all ... to transfers using disposable pipette tips, the ... bulk reagent dispenser is available for transferring ...
Biology Products: